MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer

被引:1
作者
Xu, Wei [1 ]
Hang, Meng [1 ]
Yuan, Chen-Ye [1 ]
Wu, Fu-Lin [1 ]
Chen, Shu-Bo [1 ]
Xue, Kai [2 ]
机构
[1] Nanjing Med Univ, Affiliated Wuxi Hosp 2, Med Oncol, Wuxi 214002, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Med Oncol, Shanghai 200032, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2015年 / 8卷 / 04期
基金
中国国家自然科学基金;
关键词
Non-small cell lung cancer; miR-139-5p; insulin-like growth factor 1 receptor; PROMOTES; MIR-139-5P; APOPTOSIS; IGF1R;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Increasing evidence suggested that microRNAs (miRNAs) play a critical role in tumorigenesis. Decreased expression of miRNA-139-5p has been observed in various types of cancers. However, the biological function of miRNA-139-5p in non-small cell lung cancer (NSCLC) is still largely unknown. Methods: Quantitative real-time PCR (qRT-PCR) was used to explore the expression level of miRNA-139-5p in NSCLC tissues and cell lines. Then, we investigated the role of miRNA-139-5p to determine its potential roles on lung cancer cell proliferation, migration and invasion in vitro. A luciferase reporter assay was performed to confirm the target gene of miRNA-139-5p and the results were validated in renal cancer cells. Results: miRNA-139-5p was significantly decreased in NSCLC tissues and cell lines. Over-expression of miRNA-139-5p could inhibit lung cancer cell proliferation, migration, and invasion in vitro. Furthermore, we identified insulin-like growth factor 1 receptor (IGF1R) as a target of miR-139-5p and miR-139-5p function as a tumor suppressor via targeting IGF1R in NSCLC. Conclusions: Our results indicated that miR-139-5p acts as a tumor suppressor in NSCLC partially via down-regulating IGF1R expression.
引用
收藏
页码:3864 / 3870
页数:7
相关论文
共 22 条
  • [1] [Anonymous], 2020, CA Cancer J Clin, DOI DOI 10.3322/CAAC.21590
  • [2] MicroRNAs: Target Recognition and Regulatory Functions
    Bartel, David P.
    [J]. CELL, 2009, 136 (02) : 215 - 233
  • [3] miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer
    Corcoran, Claire
    Rani, Sweta
    Breslin, Susan
    Gogarty, Martina
    Ghobrial, Irene M.
    Crown, John
    O'Driscoll, Lorraine
    [J]. MOLECULAR CANCER, 2014, 13
  • [4] Causes and consequences of microRNA dysregulation in cancer
    Croce, Carlo M.
    [J]. NATURE REVIEWS GENETICS, 2009, 10 (10) : 704 - 714
  • [5] Non Small Cell Lung Cancer
    Ettinger, David S.
    Akerley, Wallace
    Bepler, Gerold
    Blum, Matthew G.
    Chang, Andrew
    Cheney, Richard T.
    Chirieac, Lucian R.
    D'Amico, Thomas A.
    Demmy, Todd L.
    Ganti, Apar Kishor P.
    Govindan, Ramaswamy
    Grannis, Frederic W., Jr.
    Jahan, Thierry
    Jahanzeb, Mohammad
    Johnson, David H.
    Kessinger, Anne
    Komaki, Ritsuko
    Kong, Feng-Ming
    Kris, Mark G.
    Krug, Lee M.
    Le, Quynh-Thu
    Lennes, Inga T.
    Martins, Renato
    O'Malley, Janis
    Osarogiagbon, Raymond U.
    Otterson, Gregory A.
    Patel, Jyoti D.
    Pisters, Katherine M.
    Reckamp, Karen
    Riely, Gregory J.
    Rohren, Eric
    Simon, George R.
    Swanson, Scott J.
    Wood, Douglas E.
    Yang, Stephen C.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (07): : 740 - +
  • [6] The insulin-like growth factor 1 receptor in cancer: Old focus, new future
    Hartog, Hermien
    Wesseling, Jelle
    Boezen, H. Marike
    van der Graaf, Winette T. A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (13) : 1895 - 1904
  • [7] Micrornas: Small RNAs with a big role in gene regulation
    He, L
    Hannon, GJ
    [J]. NATURE REVIEWS GENETICS, 2004, 5 (07) : 522 - 531
  • [8] miR-139-5p is a regulator of metastatic pathways in breast cancer
    Krishnan, Keerthana
    Steptoe, Anita L.
    Martin, Hilary C.
    Pattabiraman, Diwakar R.
    Nones, Katia
    Waddell, Nic
    Mariasegaram, Mythily
    Simpson, Peter T.
    Lakhani, Sunil R.
    Vlassov, Alexander
    Grimmond, Sean M.
    Cloonan, Nicole
    [J]. RNA, 2013, 19 (12) : 1767 - 1780
  • [9] Role of insulin-like growth factor 1 receptor signalling in cancer
    Larsson, O
    Girnita, A
    Girnita, L
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (12) : 2097 - 2101
  • [10] MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways
    Li, X-J
    Luo, X-Q
    Han, B-W
    Duan, F-T
    Wei, P-P
    Chen, Y-Q
    [J]. BRITISH JOURNAL OF CANCER, 2013, 109 (08) : 2189 - 2198